Walleye Trading’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Walleye Trading’s Portfolio RXDX Stock Details RXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,700	Closed	-$182K	–	5394
2023 Q1	$182K	Buy	+1,700	New	+$196K	﹤0.01%	3569
2022 Q4	–	Sell	-5,100	Closed	-$301K	–	5584
2022 Q3	$301K	Buy	+5,100	New	+$233K	﹤0.01%	3374

Other funds holding RXDX

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

FCA

FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

Walleye Trading's RXDX Position: Q2 2023 in Review

Walleye Trading sold out of Prometheus Biosciences, Inc. Common Stock (RXDX) in Q2 2023, closing a stake of 58 shares — an estimated $6.22K sold.

Walleye Trading first reported a position in RXDX in Q1 2023 and held it in 1 quarter. The position peaked at $6.22K in Q1 2023. 2 funds tracked by Wall St. Rank hold RXDX as of Q2 2023.

Walleye Trading reported no remaining Prometheus Biosciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Walleye Trading sold 58 Prometheus Biosciences, Inc. Common Stock shares in Q2 2023, an estimated $6.22K.
Walleye Trading first reported a position in Prometheus Biosciences, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
Walleye Trading's Prometheus Biosciences, Inc. Common Stock position peaked at $6.22K in Q1 2023.
2 funds tracked by Wall St. Rank held Prometheus Biosciences, Inc. Common Stock as of Q2 2023.

Based on Walleye Trading's 13F filing for Q2 2023, filed 14 Aug 2023.